Treatment for Hereditary Breast Cancer Not Always Guideline-Concordant
Treatment seems less in line with practice guidelines, particularly for radiation therapy and chemotherapy
Diagnosis & Disease Information
Nonadherence to Tamoxifen Higher Than Reported Among Premenopausal Patients With Breast Cancer
Assessment of a subgroup of a cohort study revealed that many patients undergoing tamoxifen therapy for early-stage breast cancer do not adhere to their prescribed treatment, even though they claim adherence on patient surveys.
Hypofractionated Radiotherapy After Conservative Surgery May Increase Low-intermediate Grade Late Fibrosis in Breast Cancer Patients
[Breast Cancer: Targets and Therapy] Researchers sought to determine the incidence of subcutaneous side effects in patients with early-stage breast cancer treated with AHF-RT vs standard fractionated RT after breast conserving surgery.
Spotlight on Triptorelin in the Treatment of Premenopausal Women with Early-Stage Breast Cancer
[Breast Cancer: Targets and Therapy] Researchers present a review of the LHRH agonist triptorelin and the use of this agent to induce chemical castration in estrogen-sensitive breast cancer tumors in younger women.
Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
Study findings presented at SABCS 2017 demonstrate that intermediate Oncotype DX scores are prognostic of overall survival for patients with early-stage breast cancer, particularly in younger women with the disease.
Higher CAM Use Associated With Decreased Chemo Initiation
Researchers examined possible correlations between complementary and alternative medicine and delayed initiation of clinically indicated chemotherapy among patients with early-stage breast cancer.
- Loading...
Loading...
Next post in Breast Cancer
Loading... 
Loading...